High prevalence of aggregative adherent Escherichia coli strains in the mucosa-associated microbiota of patients with inflammatory bowel diseases - PubMed (original) (raw)
High prevalence of aggregative adherent Escherichia coli strains in the mucosa-associated microbiota of patients with inflammatory bowel diseases
Cristiane M Thomazini et al. Int J Med Microbiol. 2011 Aug.
Abstract
The intestinal population of Escherichia coli is increased in patients with inflammatory bowel disease (IBD), but the reason for this elevation, the particular features of these bacteria and their potential role in the pathogenesis of the disease are not known. The present study was undertaken to investigate the adherence abilities and some virulence properties of a collection of 131 E. coli isolates cultured from rectal biopsies of 23 subjects diagnosed with ulcerative colitis (UC), 8 with Crohn's disease (CD) and 23 control patients from southern Brazil. The adherence abilities of the bacteria were investigated in vitro, using HEp-2 epithelial cells in assays of 3 and 6h of bacteria-cell contact. The isolates were screened by PCR with primers for the following virulence genetic markers: plasmid of aggregative adhesion (pAA) and the aggregative adherence fimbriae R (aggR), E. coli attaching and effacing (eae), invasion-associated locus (ial), invasion plasmid antigen H (ipaH) and Shiga citotoxin-encoding (stx) genes. HEp-2 cells aggregative adherent E. coli strains, as detected in the 3h adherence assay, were found in 14/23 (60.9%) patients with UC, 7/8 (87.5%) with CD and in 7/23 (30.4%) controls (p=0.011). Virulence genetic markers were detected in strains of 9 patients with UC (39.1%), but in none of CD or control group. Two of these UC patients had strains harboring both pAA and aggR, one had strains positive for aggR, four had strains positive for eae and two had strains positive for stx. These results suggest that the augmented population of E. coli on the rectal mucosa of IBD patients, particularly of those diagnosed with UC, is mostly comprised of aggregative adherent strains, some of which possessing classical virulence markers of E. coli.
Copyright © 2011 Elsevier GmbH. All rights reserved.
Similar articles
- The prevalence of mucosa-associated diffusely adherent Escherichia coli in children with inflammatory bowel disease.
Walczuk U, Sobieszczańska B, Turniak M, Rzeszutko M, Duda-Madej A, Iwańczak B. Walczuk U, et al. Adv Clin Exp Med. 2019 Jul;28(7):899-905. doi: 10.17219/acem/94149. Adv Clin Exp Med. 2019. PMID: 31066244 - Quantification and characterization of mucosa-associated and intracellular Escherichia coli in inflammatory bowel disease.
Elliott TR, Hudspith BN, Wu G, Cooley M, Parkes G, Quiñones B, Randall L, Mandrell RE, Fagerquist CK, Brostoff J, Rayment NB, Boussioutas A, Petrovska L, Sanderson JD. Elliott TR, et al. Inflamm Bowel Dis. 2013 Oct;19(11):2326-38. doi: 10.1097/MIB.0b013e3182a38a92. Inflamm Bowel Dis. 2013. PMID: 23989750 - Phenotypic and genotypic characterisation of Escherichia coli strains serogrouped as enteropathogenic E. coli (EPEC) isolated from pasteurised milk.
Carneiro LA, Lins MC, Garcia FR, Silva AP, Mauller PM, Alves GB, Rosa AC, Andrade JR, Freitas-Almeida AC, Queiroz ML. Carneiro LA, et al. Int J Food Microbiol. 2006 Apr 15;108(1):15-21. doi: 10.1016/j.ijfoodmicro.2005.10.010. Epub 2006 Feb 20. Int J Food Microbiol. 2006. PMID: 16490272 - Enteroaggregative Escherichia coli an emergent pathogen with different virulence properties.
Villaseca JM, Hernández U, Sainz-Espuñes TR, Rosario C, Eslava C. Villaseca JM, et al. Rev Latinoam Microbiol. 2005 Jul-Dec;47(3-4):140-59. Rev Latinoam Microbiol. 2005. PMID: 17061538 Review. - Adherent-invasive Escherichia coli: a putative new E. coli pathotype associated with Crohn's disease.
Darfeuille-Michaud A. Darfeuille-Michaud A. Int J Med Microbiol. 2002 Sep;292(3-4):185-93. doi: 10.1078/1438-4221-00201. Int J Med Microbiol. 2002. PMID: 12398209 Review.
Cited by
- Enteroaggregative Escherichia coli promotes transepithelial migration of neutrophils through a conserved 12-lipoxygenase pathway.
Boll EJ, Struve C, Sander A, Demma Z, Krogfelt KA, McCormick BA. Boll EJ, et al. Cell Microbiol. 2012 Jan;14(1):120-32. doi: 10.1111/j.1462-5822.2011.01706.x. Epub 2011 Oct 27. Cell Microbiol. 2012. PMID: 21951973 Free PMC article. - The Role of Enterobacteriaceae in Gut Microbiota Dysbiosis in Inflammatory Bowel Diseases.
Baldelli V, Scaldaferri F, Putignani L, Del Chierico F. Baldelli V, et al. Microorganisms. 2021 Mar 27;9(4):697. doi: 10.3390/microorganisms9040697. Microorganisms. 2021. PMID: 33801755 Free PMC article. Review. - Possible role of Escherichia coli in propagation and perpetuation of chronic inflammation in ulcerative colitis.
Pilarczyk-Zurek M, Chmielarczyk A, Gosiewski T, Tomusiak A, Adamski P, Zwolinska-Wcislo M, Mach T, Heczko PB, Strus M. Pilarczyk-Zurek M, et al. BMC Gastroenterol. 2013 Apr 8;13:61. doi: 10.1186/1471-230X-13-61. BMC Gastroenterol. 2013. PMID: 23566070 Free PMC article. - Inactivation of the Pyrimidine Biosynthesis pyrD Gene Negatively Affects Biofilm Formation and Virulence Determinants in the Crohn's Disease-Associated Adherent Invasive Escherichia coli LF82 Strain.
Rossi E, Leccese G, Baldelli V, Bibi A, Scalone E, Camilloni C, Paroni M, Landini P. Rossi E, et al. Microorganisms. 2022 Feb 28;10(3):537. doi: 10.3390/microorganisms10030537. Microorganisms. 2022. PMID: 35336113 Free PMC article. - IBD-what role do Proteobacteria play?
Mukhopadhya I, Hansen R, El-Omar EM, Hold GL. Mukhopadhya I, et al. Nat Rev Gastroenterol Hepatol. 2012 Feb 21;9(4):219-30. doi: 10.1038/nrgastro.2012.14. Nat Rev Gastroenterol Hepatol. 2012. PMID: 22349170 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical